GO:0004691 cAMP-dependent protein kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004691 describes the molecular function of cAMP-dependent protein kinase (PKA), which catalyzes the transfer of the gamma-phosphate of ATP to serine or threonine residues on protein substrates.
• PKA is a tetrameric holoenzyme composed of two regulatory (R) subunits and two catalytic (C) subunits; cAMP binding to the R subunits releases active C subunits.
• The catalytic mechanism involves a conserved ATP-binding pocket, a catalytic loop, and a magnesium-dependent phosphotransfer reaction.
• PKA activity is regulated by compartmentalized cAMP signaling, phosphodiesterases, A-kinase anchoring proteins (AKAPs), and post-translational modifications such as glutathionylation.
• Dysregulated PKA signaling is implicated in cancer, infectious diseases, and neurological disorders, making it a target for drug design.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable precise dissection of PKA subunit functions in health and disease.
Description
cAMP-dependent protein kinase activity (GO:0004691) is a fundamental molecular function that mediates many cellular responses to the second messenger cyclic AMP (cAMP). This activity is carried out by protein kinase A (PKA), a serine/threonine kinase that phosphorylates a wide array of substrate proteins, thereby modulating processes such as metabolism, gene expression, cell proliferation, and differentiation. The importance of PKA is underscored by its evolutionary conservation and its involvement in numerous physiological and pathological conditions. Researchers studying signal transduction, cancer biology, and infectious diseases frequently focus on PKA because it serves as a central node in cAMP signaling networks. Understanding the precise mechanisms, regulation, and substrate specificity of PKA is essential for developing targeted therapeutics and for interpreting experimental data in cellular models. This article provides a comprehensive overview of GO:0004691, covering its definition, mechanism, key genes, disease associations, and modern research methods including CRISPR-based approaches.
cAMP-dependent protein kinase activity At A Glance
| GO ID | GO:0004691 |
|---|---|
| GO term | cAMP-dependent protein kinase activity |
| Ontology | molecular_function |
| Synonym | PKA, protein kinase A activity, cAMP-dependent protein kinase, STK22, AMPK (historical) |
| Major function | Phosphorylation of serine/threonine residues on target proteins in response to cAMP signaling |
| Reaction | ATP + a protein = ADP + a phosphoprotein |
| Cofactors | Mg2+ or Mn2+ required for phosphotransfer |
| Regulation | Activated by cAMP binding to regulatory subunits; modulated by AKAPs, phosphodiesterases, and glutathionylation |
| Subcellular location | Cytoplasm, nucleus, mitochondria, and other compartments via AKAP anchoring |
What Is GO:0004691?
GO:0004691, cAMP-dependent protein kinase activity, is defined as the catalysis of the reaction: ATP + a protein = ADP + a phosphoprotein, where the activity is dependent on cyclic AMP (cAMP). This activity is synonymous with protein kinase A (PKA) and represents the ability of the enzyme to transfer the terminal phosphate group from ATP to serine or threonine residues on protein substrates, a process that is allosterically activated by cAMP binding to the regulatory subunits of the PKA holoenzyme.
Why Is cAMP-dependent protein kinase activity Important in Cell Biology?
cAMP-dependent protein kinase activity is a central hub in cellular signal transduction, translating fluctuations in cAMP levels into specific phosphorylation events that control metabolism, gene transcription, cell growth, and survival. Its dysregulation is linked to a broad spectrum of human diseases, including various cancers, infectious diseases, and neurological disorders. Moreover, PKA serves as a paradigm for understanding kinase structure, allostery, and substrate recognition, making it a key subject in biochemistry and pharmacology.
• PKA phosphorylates key metabolic enzymes, thereby regulating glucose and lipid metabolism.
• It controls gene expression by phosphorylating transcription factors such as CREB.
• PKA activity is essential for neuronal signaling, learning, and memory.
• Dysregulated PKA signaling contributes to tumorigenesis and cancer progression.
• Pathogens such as Coxiella burnetii exploit host PKA to promote macrophage survival.
• PKA is a target for drug design, with inhibitors and activators being explored for therapeutic use.
• The enzyme is regulated by subcellular anchoring and post-translational modifications, influencing specificity.
• PKA serves as a model system for studying kinase mechanism and allosteric regulation.
• Mutations in PKA subunits are associated with endocrine disorders and developmental syndromes.
• CRISPR screens can identify novel components of PKA signaling pathways.
What Happens During cAMP-dependent protein kinase activity?
Activation by cAMP
In simple terms: cAMP binds to the regulatory subunits of PKA, causing them to release the active catalytic subunits.
In the absence of cAMP, PKA exists as an inactive tetramer of two regulatory (R) and two catalytic (C) subunits. Binding of cAMP to the R subunits induces a conformational change that lowers the affinity for the C subunits, leading to their dissociation and activation. This step is the primary mechanism by which cAMP levels are translated into PKA activity.
Substrate recognition and phosphorylation
In simple terms: The active catalytic subunit finds target proteins and attaches a phosphate group to specific serine or threonine residues.
The free catalytic subunit recognizes substrate proteins containing a consensus sequence (RRXS/T) and catalyzes the transfer of the gamma-phosphate from ATP to the hydroxyl group of serine or threonine. This phosphorylation event alters the substrate's activity, localization, or interactions, propagating the signal.
Termination and resetting
In simple terms: Phosphodiesterases degrade cAMP, and phosphatases remove phosphate groups, turning off the signal.
Signal termination involves the hydrolysis of cAMP by phosphodiesterases and the dephosphorylation of substrates by protein phosphatases. The R and C subunits then reassociate to reform the inactive holoenzyme, ready for another cycle.
Compartmentalization and specificity
In simple terms: Scaffolding proteins anchor PKA near specific targets, ensuring that only the right proteins get phosphorylated.
A-kinase anchoring proteins (AKAPs) bind the R subunits and localize PKA to distinct subcellular compartments, such as the plasma membrane, mitochondria, or nucleus. This spatial regulation ensures substrate specificity and efficient signal transduction.
Key Genes Involved in GO:0004691 cAMP-dependent protein kinase activity
The following genes encode the subunits and regulators of cAMP-dependent protein kinase activity, and they are frequently studied in cellular and disease models.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRKACA | Catalytic subunit alpha | Most widely expressed C subunit; mutations linked to adrenal Cushing's syndrome and cancer |
| PRKACB | Catalytic subunit beta | Alternative C subunit with distinct substrate specificity; involved in neuronal signaling |
| PRKACG | Catalytic subunit gamma | Testis-specific C subunit; potential role in spermatogenesis |
| PRKAR1A | Regulatory subunit type I alpha | Mutations cause Carney complex; key regulator of PKA activity |
| PRKAR1B | Regulatory subunit type I beta | Neuronal R subunit; implicated in neurodegenerative disorders |
| PRKAR2A | Regulatory subunit type II alpha | Anchored by AKAPs; regulates PKA localization |
| PRKAR2B | Regulatory subunit type II beta | Involved in metabolic regulation and insulin secretion |
| AKAP1 | A-kinase anchoring protein 1 | Mitochondrial anchoring; regulates PKA-dependent apoptosis |
| AKAP5 | A-kinase anchoring protein 5 | Postsynaptic anchoring; modulates neuronal plasticity |
| AKAP6 | A-kinase anchoring protein 6 | Nuclear anchoring; controls gene transcription |
| CREB1 | cAMP response element-binding protein | Major PKA substrate; regulates gene expression |
| CFTR | Cystic fibrosis transmembrane conductance regulator | Phosphorylated by PKA; regulates chloride transport |
| RYR2 | Ryanodine receptor 2 | PKA phosphorylation modulates calcium release in heart |
| GSK3B | Glycogen synthase kinase 3 beta | Cross-talk with PKA signaling in metabolism |
| PDE4D | Phosphodiesterase 4D | Degrades cAMP; regulates PKA activity |
| PPP1R1B | Protein phosphatase 1 regulatory subunit 1B | Dopamine- and cAMP-regulated phosphoprotein; PKA substrate |
| RAPGEF3 | Exchange protein activated by cAMP 1 | cAMP effector independent of PKA; cross-regulates PKA |
How Is cAMP-dependent protein kinase activity Regulated?
cAMP-dependent protein kinase activity is tightly regulated at multiple levels. The availability of cAMP is controlled by adenylyl cyclases and phosphodiesterases, which synthesize and degrade the second messenger, respectively. Subcellular localization of PKA is directed by A-kinase anchoring proteins (AKAPs), which tether the holoenzyme to specific compartments and substrates. Post-translational modifications, such as glutathionylation of the catalytic subunit, can directly modulate kinase activity. Additionally, feedback loops involving Raf kinase inhibitory protein (RKIP) regulate the cAMP-PKA signaling pathway. These regulatory mechanisms ensure that PKA activity is transient, localized, and specific to the appropriate physiological context.
cAMP-dependent protein kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRKACA | Adrenal Cushing's syndrome, adrenocortical tumors | Knock-in of activating mutation in adrenal cell lines |
| PRKAR1A | Carney complex, endocrine tumors | Knockout in patient-derived cells |
| CFTR | Cystic fibrosis, cholera | Point mutation of PKA phosphorylation sites in CFTR |
| Coxiella burnetii infection | Macrophage survival, Q fever | Knockout of PKA subunits in macrophages |
| PRKACB | Neuronal signaling, memory | Overexpression in neuronal cultures |
Cancer
Dysregulated cAMP-dependent protein kinase activity is implicated in multiple cancers. For example, mutations in PRKACA are found in adrenal Cushing's syndrome and in some adrenocortical tumors, leading to constitutive PKA activation. Extracellular cAMP-dependent protein kinase has been proposed as a tumor marker in certain malignancies. Furthermore, PKA signaling promotes cell proliferation and survival in various cancer types, making it a potential therapeutic target.
Infectious diseases
Pathogens can exploit host PKA signaling to establish infection. Coxiella burnetii, the causative agent of Q fever, utilizes host cAMP-dependent protein kinase signaling to promote macrophage survival, thereby evading immune clearance. This highlights the importance of PKA in host-pathogen interactions and suggests that modulating PKA activity could be a therapeutic strategy for infectious diseases.
Neurological disorders
PKA plays critical roles in neuronal development, synaptic plasticity, and memory formation. A cAMP-dependent, PKA-independent signaling pathway mediates neuritogenesis through Egr1 in PC12 cells, indicating that PKA-independent mechanisms also exist. However, PKA itself is essential for many aspects of neuronal function, and its dysregulation has been linked to neurodegenerative diseases and cognitive disorders.
From cAMP-dependent protein kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PRKACA mutation drive adrenal tumorigenesis? | Point-mutation knock-in in adrenal cells |
| What is the role of PRKAR1A in Carney complex? | Knockout in patient iPSCs |
| How does PKA phosphorylation regulate CFTR? | Knock-in of phospho-null CFTR |
| Does PKA activity affect macrophage survival during infection? | Knockout of PRKACA in macrophages |
| What are the substrates of PKA in neurons? | Overexpression of tagged PKA catalytic subunit |
| Can PKA inhibitors reverse cancer phenotypes? | Knockout of PKA subunits in cancer cell lines |
How to Study the cAMP-dependent protein kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro kinase assay | Phosphotransfer activity | Enzyme kinetics, inhibitor testing |
| Phosphoproteomics | Global phosphorylation changes | Substrate identification, pathway mapping |
| FRET biosensor imaging | Real-time PKA activity | Live-cell signaling dynamics |
| CRISPR knockout screen | Gene essentiality for PKA signaling | Discovery of regulators |
| Western blotting | Phosphorylation of specific substrates | Validation of PKA targets |
| Immunoprecipitation | Protein-protein interactions | Identification of PKA complexes |
| RNA-seq | Transcriptional changes | Downstream gene expression analysis |
Kinase activity assays
In vitro kinase assays using purified PKA and substrate peptides measure the transfer of radioactive or fluorescent phosphate from ATP to substrate. These assays are used to determine specific activity, kinetic parameters, and the effects of inhibitors or mutations.
Phosphoproteomics
Mass spectrometry-based phosphoproteomics identifies global changes in protein phosphorylation upon PKA activation or inhibition. This approach reveals novel substrates and signaling networks regulated by cAMP-dependent protein kinase activity.
Live-cell imaging
Genetically encoded FRET biosensors for PKA activity allow real-time monitoring of kinase dynamics in living cells with subcellular resolution. These tools are valuable for studying compartmentalized signaling and drug responses.
CRISPR screens
Genome-wide CRISPR knockout or activation screens can identify genes that modulate PKA signaling or that are required for PKA-dependent phenotypes. Such screens have uncovered regulators like RKIP and potential therapeutic targets.
How CRISPR Can Be Used to Study GO:0004691 cAMP-dependent protein kinase activity
Knockout
CRISPR knockout of PKA subunit genes (e.g., PRKACA, PRKAR1A) in cell lines or primary cells abolishes specific subunit functions, enabling researchers to dissect their roles in signaling and disease. For example, knockout of PRKACA in macrophages can test its requirement for Coxiella burnetii survival.
Point Mutation
Introducing point mutations that alter catalytic activity (e.g., kinase-dead) or regulatory properties (e.g., cAMP-binding deficient) allows precise structure-function analysis. Such models are useful for studying mutations found in human diseases like adrenal Cushing's syndrome.
Knock-in
Knock-in of tagged PKA subunits (e.g., GFP or HA) enables visualization and immunoprecipitation of endogenous complexes. Knock-in of disease-associated mutations (e.g., PRKACA L206R) in cell lines or animal models recapitulates pathological phenotypes.
Overexpression
Overexpression of wild-type or mutant PKA subunits using CRISPR activation or lentiviral delivery can amplify signaling and reveal gain-of-function phenotypes. This approach is particularly useful for studying substrate specificity and cellular transformation.
How EDITGENE Supports cAMP-dependent protein kinase activity Research
Researchers studying cAMP-dependent protein kinase activity-related genes often need to determine whether a candidate gene is causally involved in a specific signaling pathway or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of PKA components and their regulators.
Contact EDITGENE today to design your custom CRISPR model for cAMP-dependent protein kinase activity research.
Frequently Asked Questions About cAMP-dependent protein kinase activity
What is cAMP-dependent protein kinase activity?
cAMP-dependent protein kinase activity (GO:0004691) is the enzymatic function of protein kinase A (PKA), which phosphorylates serine or threonine residues on target proteins in response to cyclic AMP (cAMP) signaling.
What genes are involved in cAMP-dependent protein kinase activity?
Key genes include PRKACA, PRKACB, and PRKACG encoding catalytic subunits, and PRKAR1A, PRKAR1B, PRKAR2A, and PRKAR2B encoding regulatory subunits, as well as AKAPs that anchor the enzyme.
How is cAMP-dependent protein kinase activity regulated?
It is regulated by cAMP levels, phosphodiesterases, A-kinase anchoring proteins (AKAPs), and post-translational modifications such as glutathionylation.
What diseases are associated with cAMP-dependent protein kinase activity?
Dysregulation is linked to cancers (e.g., adrenal Cushing's syndrome), infectious diseases (e.g., Q fever), and neurological disorders.
What is the reaction catalyzed by cAMP-dependent protein kinase?
The enzyme catalyzes the transfer of the gamma-phosphate from ATP to a protein substrate, producing ADP and a phosphoprotein.
How can CRISPR be used to study cAMP-dependent protein kinase activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of PKA subunit genes to study their functions in signaling and disease.
What are the substrates of cAMP-dependent protein kinase?
Substrates include CREB1, CFTR, RYR2, and many metabolic enzymes, typically containing a consensus RRXS/T motif.
Is cAMP-dependent protein kinase activity the same as PKA?
Yes, cAMP-dependent protein kinase activity is synonymous with protein kinase A (PKA) activity, as defined by GO:0004691.
What methods are used to measure cAMP-dependent protein kinase activity?
Common methods include in vitro kinase assays, phosphoproteomics, FRET biosensors, and Western blotting for specific phospho-substrates.
Can cAMP-dependent protein kinase activity be targeted therapeutically?
Yes, PKA inhibitors and activators are being explored for cancer, infectious diseases, and other conditions, though specificity remains a challenge.
Conclusion
cAMP-dependent protein kinase activity (GO:0004691) is a cornerstone of cellular signal transduction, with far-reaching implications for physiology and disease. Its precise regulation and diverse substrates make it a rich area of research, and CRISPR-based models are invaluable for dissecting its roles. EDITGENE's services empower researchers to generate custom cell models and conduct high-throughput screens to uncover new insights into PKA biology.
References
- 1. Lee J et al.. 2022. Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop.. Proc Natl Acad Sci U S A 119(25):e2121867119 PMID: 35696587
- 2. Lorenz R et al.. 2017. cAMP-Dependent Protein Kinase and cGMP-Dependent Protein Kinase as Cyclic Nucleotide Effectors.. Handb Exp Pharmacol 238:105-122 PMID: 27885524
- 3. Taylor SS et al.. 2008. Signaling through cAMP and cAMP-dependent protein kinase: diverse strategies for drug design.. Biochim Biophys Acta 1784(1):16-26 PMID: 17996741
- 4. Ravni A et al.. 2008. A cAMP-dependent, protein kinase A-independent signaling pathway mediating neuritogenesis through Egr1 in PC12 cells.. Mol Pharmacol 73(6):1688-708 PMID: 18362103
- 5. Meinkoth JL et al.. 1993. Signal transduction through the cAMP-dependent protein kinase.. Mol Cell Biochem 127-128:179-86 PMID: 7935349
- 6. Cho YS et al.. 2000. Biochemical characterization of extracellular cAMP-dependent protein kinase as a tumor marker.. Biochem Biophys Res Commun 278(3):679-84 PMID: 11095968
- 7. Humphries KM et al.. 2002. Regulation of cAMP-dependent protein kinase activity by glutathionylation.. J Biol Chem 277(45):43505-11 PMID: 12189155
- 8. Macdonald LJ et al.. 2014. Coxiella burnetii exploits host cAMP-dependent protein kinase signalling to promote macrophage survival.. Cell Microbiol 16(1):146-59 PMID: 24028560
